Expert Regulatory Affairs Professional Services

A regulatory affairs professional helps companies bring regulated products to market and keep them compliant after approval. Their work can include regulatory strategy, product classification, submission planning, technical documentation review, agency correspondence, labeling review, quality system alignment, and post-market obligations. In medical devices, they often support FDA, EU MDR, Health Canada, TGA, and ISO-related requirements throughout the product lifecycle.

The best time is early in development, before major testing, claims, or submission decisions are locked in. Early regulatory input helps define the right pathway, evidence plan, and documentation structure, which can prevent expensive rework later. Companies also commonly bring in support before a 510(k), PMA, CE marking effort, audit, remediation project, or expansion into a new market.

Yes. Regulatory affairs consultants often support FDA 510(k), PMA, Q-Sub, and change assessment activities. Services may include pathway selection, predicate strategy, intended use review, technical file preparation, risk management alignment, labeling review, and responses to Additional Information requests. The goal is to submit a complete, coherent package that meets FDA expectations and reduces avoidable review delays.

Yes. Elexes supports global regulatory strategies across markets including Europe, Canada, Australia, the UK, and other regions. That can include EU MDR and IVDR compliance, Health Canada licence applications, TGA consulting, classification support, technical documentation alignment, and market-specific change assessments. This is especially valuable for manufacturers managing parallel submissions or planning phased international expansion.

A submission readiness assessment is a structured review of whether your device, documentation, evidence, and quality system are truly prepared for regulatory review. It typically examines technical documentation completeness, risk management, clinical evidence, labeling, and traceability against the target pathway. The output is usually a gap-based report and prioritized action plan so teams can fix weaknesses before submitting.

It can either replace or extend an in-house function, depending on your needs. Early-stage companies often use outsourced RAQA support as their primary regulatory capability, while growing manufacturers use it to add bandwidth or specialized expertise. Elexes offers project-based, part-time, and embedded operating models, allowing companies to maintain continuity without committing to full-time internal hires.

They reduce delays by identifying gaps before submission, aligning documentation to the correct regulatory standard, improving traceability, and preparing stronger responses when authorities ask questions. Good regulatory support also helps teams avoid common issues such as weak predicate strategy, incomplete technical files, inconsistent labeling, or unsupported claims. That preparation can save months of back-and-forth during review.

These services are especially valuable for medical device manufacturers, IVD and diagnostics companies, SaMD developers, biotech firms, clinical laboratories, and combination product teams. Any organization working under FDA, EU MDR, IVDR, ISO 13485, CLIA, or similar frameworks can benefit from expert regulatory guidance. They are particularly useful when internal teams are lean or entering unfamiliar markets.